#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Malignant fibrous histiocytoma Biliary cancer metastatic Acute graft versus host disease in liver Paget's disease of the vulva Cerebral amyloid angiopathy Dilated cardiomyopathy Multiple system atrophy Microvillous inclusion disease Angiosarcoma recurrent Anal fistula Choroidal dystrophy Autologous haematopoietic stem cell transplant Angiosarcoma Leukaemia Idiopathic intracranial hypertension More trials…

    Learn about Rare Diseases

    Primary hyperoxaluria – Basic Information Mantle cell lymphoma – Trials in Disease Primary immunodeficiency syndrome – Basic Information Haemophagocytic lymphohistiocytosis – Basic Information Hereditary hypophosphataemic rickets – Trials in Disease Epidermolysis bullosa – Treatment Factor VIII deficiency – Treatment Osteosarcoma metastatic – Basic Information Usher’s syndrome – Diagnostics Paroxysmal nocturnal haemoglobinuria – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Amylase Aon-D21 Immunostimulants ORX750 Regorafenib Dasiglucagon [18F]-Altanserin Riboflavin Sodium Phosphate Tozinameran Macrogol 3350 Elraglusib Avutometinib Ganciclovir Sodium Brigatinib Brimonidine Lithium Hexaminolevulinate Rbl015.2 Brexucabtagene Autoleucel Db-Oto-3 More therapies…

    Learn about Your Condition

    Testicular germ cell cancer Immunosuppression Diarrhoea Lymphatic malformation Enteritis Aphthous ulcer PIK3CA-activated mutation Proteus syndrome Peripheral artery restenosis Generalised anxiety disorder Epilepsy Myxoid liposarcoma Aortic disorder Ewing's sarcoma recurrent Mucopolysaccharidosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Actinic keratosis

  • Study on the Effectiveness of 5% Potassium Hydroxide Solution for Treating Mild to Moderate Actinic Keratosis in Adults

    Recruiting

    3 1
    Investigated Diseases:
    • Actinic keratosis
    Investigated Drugs:
    • POTASSIUM HYDROXIDE
    Germany

  • Study on the Effectiveness of Green Tea Leaf Extract Ointment for Adults with Actinic Keratosis on the Scalp and Face

    Recruiting

    3 1 1
    Investigated Diseases:
    • Actinic keratosis
    Investigated Drugs:
    • Camellia Sinensis (Green Tea) Leaf Extract
    Germany

  • Study on the Effectiveness and Safety of Metformin and Methyl Aminolevulinate in Daylight Therapy for Actinic Keratosis Patients

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Actinic keratosis
    Investigated Drugs:
    • Metformin Embonate
    • Methyl Aminolevulinate Hydrochloride
    Spain

  • Study on Cryotherapy and Tirbanibulin for Treating Actinic Keratosis on the Scalp and Forehead in Patients Aged 18 and Older

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Tirbanibulin
    France

  • Study of Tuvatexib Ointment Compared to Placebo for Patients with Actinic Keratosis

    Not recruiting

    2 1
    Investigated Drugs:
    • TUVATEXIB
    Germany

  • Study on the Safety and Effectiveness of Imiquimod Gel and Cream for Treating Actinic Keratosis in Adults

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Actinic keratosis
    Investigated Drugs:
    • Imiquimod
    Spain
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!